MedPath

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHILODBHIDADI TAILA MATRA BASTI IN THE MANAGEMENT OF VATASHTHILA WITH SPECIAL REFERENCE TO BENIGN PROSTATIC HYPERPLASIA(BPH)

Phase 2
Conditions
Health Condition 1: - Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2020/03/024091
Lead Sponsor
PARUL INSTITUTE OF AYURVED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS HAVING THE SIGNS AND SYMPTOMS OF VATASHTHILA (BPH)

Exclusion Criteria

PATIENTS BELOW 40 YRS OF AGE. SUFFERING FROM UROGENITAL DEFORMITIES AND ANY PELVIC PATHOLOGY. UNCONTROLLED HYPERTENSION AND DM. TUBERCULOSIS. PARALYSIS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SHILODBHIDADI TAILA MATRABASTI WILL BE EFFECTIVE IN THE MANAGEMENT OF VATASHTHILATimepoint: SHILODBHIDADI TAILA MATRABASTI WILL BE EFFECTIVE IN THE MANAGEMENT OF VATASHTHILA WITHIN 4 weeks
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath